Biosimilars

23 July 2026

Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.

11 March 2026

Learn how the new FDA biosimilar development guidance can significantly lower biologic medicine costs and improve accessibility.

Search the archive

Browse by month